In the last two decades, an impressive technical revolution has taken place in the microscopic devices. Medical device manufacturers are working diligently to create value addition to existing microscopic devices such as high magnification, excellent resolution, real time image capture capabilities etc. Rising public health awareness has resulted in early disease diagnosis and burgeoning requirement of novel treatment options to counter act antibiotic resistance together drives the life science microscopy devices market.
Optical microscopy devices are further categorized as compound microscopy, confocal microscopy, phase contrast microscopy and stereo microscopy devices. It is dominating the device type segment for life science microscopy devices on account of its rampant adoption in healthcare institutes worldwide. Low device cost and technological advancements in the development of optical lenses further accentuates its market growth. Scanning probe devices are becoming popular among scientist, owing to its ability to study real time three dimensional objects with excellent magnification and image resolution.
The application segment consists of microbiology, cell biology, neuroscience, pathology, pharmacology, toxicology etc. Microbiology holds the largest market share in the application segment. This is attributed to the increasing investment in the research and development of novel treatment drugs for life threatening diseases such as Ebola, Zika and swine flu. Pharmacology will showcase rampant growth owing to high throughput screening of biological drugs being developed for the treatment of chronic diseases.
North America is presently leading the regional segment for the global life science microscopy devices. The chief factors responsible for its market success are technological advancements in the development of high magnification optical lenses and capability to obtain high resolution images. Presence of major key manufacturers such as Bruker Corporation, Nikon Corporation, Olympus Corporation, etc., further accentuates the life science microscopy devices market growth in the region. Europe holds second position on account of rampant adoption of microscopic devices in academic and research institutes. Furthermore, European Medical Agency (EMA), has expedited the approval protocols pertaining to microscopic devices. Asia Pacific is keen to progress at a rapid pace on account of rising prevalence of infectious disease and developing healthcare infrastructure.
Medical device manufacturers actively engaged in the manufacturing of microscopic devices are Leica Microsystems, Nikon Corporation, Bruker Corporation, Olympus Corporation, Carl Zeiss Microscopy GmbH, TESCAN, JEOL, Ltd., Hitachi High Technologies, Corporation and Others.
Key segments of the life science microscopy devices market
By Device Type Overview, 2015–2025 (USD Million)
- Optical microscopy devices
- Compound microscopy devices
- Confocal microscopy devices
- Phase contrast microscopy devices
- Fluorescence microscopy devices
- Stereo microscopy devices
- Others
- Electron microscopy devices
- Scanning electron microscopy devices
- Transmission electron microscopy devices
- Scanning probe microscopy devices
- Others
By Application Overview, 2015–2025 (USD Million)
- Microbiology
- Cell biology
- Bioengineering
- Pathology
- Neuroscience
- Pharmacology
- Toxicology
- Others
Geography Segment Overview, 2015–2025 (USD Million)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Rest of Middle East & Africa